Abby Glennie, manager of the abrdn UK Mid Cap Equity fund, joins us to celebrate our 250th episode by talking all things FTSE 250 - the UK’s 250 mid-sized companies. Abby and Darius discuss the types of companies listed in the FTSE 250 and their attractive qualities for long term investors. Abby also tells us that more mid-sized companies can be found in the AIM index and gives a number of examples to illustrate the long-term growth potential of mid-cap stocks and the fund’s ability to “run its winners” - including familiar names like Hollywood Bowl and Greggs.

What’s covered in this episode: 

• The type of companies listed in the FTSE 250
• Why some companies listed on the AIM market could qualify as mid-cap
• The growth potential of FTSE 250 companies
• FTSE 250 performance compared to the FTSE 100 
• What makes mid-caps attractive for active investors
• Five long-term holdings in the portfolio, including familiar names Hollywood Bowl and Greggs
• How the ‘Matrix’ aids in stock selection and portfolio construction
• The fund’s two quality factors: Key and Z-scores
• The investment case for gaming company Keyword Studios
• Why people got the gaming sector wrong during Covid
• The hidden strength’s that could drive Greggs’ future growth

More about this fund:
The abrdn UK Mid Cap Equity is a high conviction strategy which invests in medium-sized companies for the long term. It focuses on businesses when they are well established, but still have a long runway of growth potential. Manager Abby Glennie has delivered excellent performance across a number of strategies. This fund is no exception. Her process leans on abrdn’’s screening tool, ‘The Matrix’, and is backed up with rigorous fundamental research and regular company meetings.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.